Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A systematic review of herpes zoster incidence and consensus recommendations on vaccination in adult patients on systemic therapy for psoriasis or psoriatic arthritis: From the Medical Board of the National Psoriasis Foundation
Emily Baumrin, Abby Van Voorhees, Amit Garg, et al.
Journal of the American Academy of Dermatology (2019) Vol. 81, Iss. 1, pp. 102-110
Closed Access | Times Cited: 68

Showing 1-25 of 68 citing articles:

Deucravacitinib in plaque psoriasis: Safety and efficacy through 3 years in Japanese patients in the phase 3 POETYK PSO‐1, PSO‐4, and LTE trials
Akimichi Morita, Shinichi Imafuku, Yayoi Tada, et al.
The Journal of Dermatology (2025)
Open Access | Times Cited: 1
Herpes Zoster Presentation, Management, and Prevention: A Modern Case-Based Review
Lorraine L Rosamilia
American Journal of Clinical Dermatology (2019) Vol. 21, Iss. 1, pp. 97-107
Closed Access | Times Cited: 66
Efficacy and serious adverse events profile of the adjuvanted recombinant zoster vaccine in adults with pre-existing potential immune-mediated diseases: a pooled post hoc analysis on two parallel randomized trials
Alemnew F. Dagnew, Debora A. Rausch, Caroline Hervé, et al.
Lara D. Veeken (2020) Vol. 60, Iss. 3, pp. 1226-1233
Open Access | Times Cited: 52
An evidence-based guide to SARS-CoV-2 vaccination of patients on immunotherapies in dermatology
Louise Gresham, Barbara Marzario, Jan Dutz, et al.
Journal of the American Academy of Dermatology (2021) Vol. 84, Iss. 6, pp. 1652-1666
Open Access | Times Cited: 49
Adverse events of special interest in clinical trials of rheumatoid arthritis, psoriatic arthritis, ulcerative colitis and psoriasis with 37 066 patient-years of tofacitinib exposure
Gerd R Burmester, Peter Nash, Bruce E. Sands, et al.
RMD Open (2021) Vol. 7, Iss. 2, pp. e001595-e001595
Open Access | Times Cited: 43
Herpes zoster in patients with inflammatory arthritides or ulcerative colitis treated with tofacitinib, baricitinib or upadacitinib: a systematic review of clinical trials and real-world studies
Chrysoula G. Gialouri, Savvina Moustafa, Κonstantinos Thomas, et al.
Rheumatology International (2023) Vol. 43, Iss. 3, pp. 421-435
Open Access | Times Cited: 19
Safety of recombinant zoster vaccine: a retrospective study of 622 rheumatology patients
Tiphaine Lenfant, Yuxuan Jin, E. Kirchner, et al.
Lara D. Veeken (2021) Vol. 60, Iss. 11, pp. 5149-5157
Closed Access | Times Cited: 38
Infections in the era of immunobiologicals
Ricardo Romiti, André Luís da Silva Hirayama, Adriana María Porro, et al.
Anais Brasileiros de Dermatologia (2024) Vol. 99, Iss. 2, pp. 167-180
Open Access | Times Cited: 5
Vaccinations in Selected Immune-Related Diseases Treated with Biological Drugs and JAK Inhibitors—Literature Review and Statement of Experts from Polish Dermatological Society
Joanna Narbutt, Zbigniew Żuber, Aleksandra Lesiak, et al.
Vaccines (2024) Vol. 12, Iss. 1, pp. 82-82
Open Access | Times Cited: 4
Systemic therapy for psoriasis and the risk of cutaneous infections
Yuko Higashi, Shinichi Imafuku, Noriko Tsuruta, et al.
The Journal of Dermatology (2024) Vol. 51, Iss. 7, pp. 939-949
Open Access | Times Cited: 4
Prevention and management of herpes zoster in patients with rheumatoid arthritis and psoriatic arthritis: a clinical review
Kevin Winthrop, Yoshiya Tanaka, Eun Bong Lee, et al.
Clinical and Experimental Rheumatology (2022) Vol. 40, Iss. 1, pp. 162-172
Open Access | Times Cited: 18
Comorbid Infections in Spondyloarthritis: the Current State of the Problem
М. М. Баранова, N. V. Muravyevа, Б. С. Белов
Antibiot Khimioter = Antibiotics and Chemotherapy (2025) Vol. 69, Iss. 11-12, pp. 127-135
Open Access
Herpes zoster – Prävention, Diagnostik und Behandlung
Ricardo Niklas Werner, Kamran Ghoreschi
Der Hautarzt (2022) Vol. 73, Iss. 6, pp. 442-451
Closed Access | Times Cited: 15
Vaccination recommendations for adults receiving biologics and oral therapies for psoriasis and psoriatic arthritis: Delphi consensus from the medical board of the National Psoriasis Foundation
Vipawee S. Chat, Christoph T. Ellebrecht, Paige Kingston, et al.
Journal of the American Academy of Dermatology (2024) Vol. 90, Iss. 6, pp. 1170-1181
Closed Access | Times Cited: 3
Anti-Herpes zoster vaccination in patients with dermatologic diseases: a position statement from the Italian SIDeMaST group of sexually transmitted, infectious and tropical diseases
Giulia Ciccarese, Francesco Drago, Astrid Herzum, et al.
Italian Journal of Dermatology and Venereology (2024) Vol. 159, Iss. 4
Open Access | Times Cited: 3
Knowledge, Attitudes, and Practices Regarding Herpes Zoster Vaccination Among Specialists
David Singer, Carolyn Sweeney, Nikita Stempniewicz, et al.
Population Health Management (2024) Vol. 27, Iss. 4, pp. 231-240
Closed Access | Times Cited: 3
Preventing herpes zoster in immunocompromised patients: Current concepts
Cassandra Calabrese, E. Kirchner, James Fernandez, et al.
Cleveland Clinic Journal of Medicine (2024) Vol. 91, Iss. 7, pp. 437-445
Open Access | Times Cited: 3
Vaccination Recommendations for Psoriasis and Atopic Dermatitis Patients on Biologic Therapy: A Practical Guide.
Ryan Fan, Jeffrey M. Cohen
PubMed (2022) Vol. 95, Iss. 2, pp. 249-255
Closed Access | Times Cited: 14
Recombinant Zoster Vaccine Uptake and Risk of Flares Among Older Adults With Immune‐Mediated Inflammatory Diseases in the US
Jessica Leung, Tara C. Anderson, Kathleen Dooling, et al.
Arthritis & Rheumatology (2022) Vol. 74, Iss. 11, pp. 1833-1841
Closed Access | Times Cited: 13
Herpes zoster and Janus kinase inhibition in rheumatology and gastroenterology patients: managing risk and vaccination
James Galloway, Tim Raine, Lucy Rivett, et al.
Clinical and Experimental Rheumatology (2021)
Open Access | Times Cited: 15
Systematic review and critical appraisal of psoriasis clinical practice guidelines: a Global Guidelines in Dermatology Mapping Project ( GUIDEMAP )*
Hsi Yen, Chun‐Hsien Huang, I‐Hsin Huang, et al.
British Journal of Dermatology (2022) Vol. 187, Iss. 2, pp. 178-187
Open Access | Times Cited: 11
<p>Tofacitinib in the management of active psoriatic arthritis: patient selection and perspectives</p>
Karen Ly, Kristen M. Beck, Mary Patricia Smith, et al.
Psoriasis Targets and Therapy (2019) Vol. Volume 9, pp. 97-107
Open Access | Times Cited: 17
Association of herpes zoster and chronic inflammatory skin disease in US inpatients
Raj Chovatiya, Jonathan I. Silverberg
Journal of the American Academy of Dermatology (2020) Vol. 85, Iss. 6, pp. 1437-1445
Open Access | Times Cited: 16
Immunizations in immunocompromised patients: a guide for dermatologists
Sophia Mohme, Marc Schmalzing, F. Max Müller, et al.
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2020) Vol. 18, Iss. 7, pp. 699-723
Open Access | Times Cited: 16
Atopic Dermatitis as a Risk Factor for Herpes Zoster Infection Independent of Treatment: A Nationwide Population-Based Cohort Study
Shou‐En Wu, Yi‐Hsien Chen, Chi‐Hsiang Chung, et al.
Dermatitis (2023) Vol. 34, Iss. 3, pp. 241-249
Closed Access | Times Cited: 5
Page 1 - Next Page

Scroll to top